Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways.

Allen JL, Fore MS, Wooten J, Roehrs PA, Bhuiya NS, Hoffert T, Sharf A, Deal AM, Armistead P, Coghill J, Gabriel DA, Irons R, Essenmacher A, Shea TC, Richards K, Cutler C, Ritz J, Serody J, Baldwin AS, Sarantopoulos S.

Blood. 2012 Sep 20;120(12):2529-36. Epub 2012 Aug 14.

2.

Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host disease.

Jacobson CA, Sun L, Kim HT, McDonough SM, Reynolds CG, Schowalter M, Koreth J, Cutler CS, Ho VT, Alyea EP, Armand P, Blazar BR, Soiffer RJ, Antin JH, Ritz J, Sarantopoulos S.

Biol Blood Marrow Transplant. 2014 May;20(5):668-75. doi: 10.1016/j.bbmt.2014.01.021. Epub 2014 Jan 23.

3.

Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.

Sarantopoulos S, Stevenson KE, Kim HT, Cutler CS, Bhuiya NS, Schowalter M, Ho VT, Alyea EP, Koreth J, Blazar BR, Soiffer RJ, Antin JH, Ritz J.

Blood. 2009 Apr 16;113(16):3865-74. doi: 10.1182/blood-2008-09-177840. Epub 2009 Jan 23.

4.

CD19(+)CD21(low) B cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome.

Kuzmina Z, Krenn K, Petkov V, Körmöczi U, Weigl R, Rottal A, Kalhs P, Mitterbauer M, Ponhold L, Dekan G, Greinix HT, Pickl WF.

Blood. 2013 Mar 7;121(10):1886-95. doi: 10.1182/blood-2012-06-435008. Epub 2013 Jan 9.

5.

Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease.

Sarantopoulos S, Stevenson KE, Kim HT, Washel WS, Bhuiya NS, Cutler CS, Alyea EP, Ho VT, Soiffer RJ, Antin JH, Ritz J.

Blood. 2011 Feb 17;117(7):2275-83. doi: 10.1182/blood-2010-10-307819. Epub 2010 Nov 19.

6.

Increased BCR responsiveness in B cells from patients with chronic GVHD.

Allen JL, Tata PV, Fore MS, Wooten J, Rudra S, Deal AM, Sharf A, Hoffert T, Roehrs PA, Shea TC, Serody JS, Richards KL, Jagasia M, Lee SJ, Rizzieri D, Horwitz ME, Chao NJ, Sarantopoulos S.

Blood. 2014 Mar 27;123(13):2108-15. doi: 10.1182/blood-2013-10-533562. Epub 2014 Feb 14.

7.

B cells in chronic graft-versus-host disease.

Sarantopoulos S, Blazar BR, Cutler C, Ritz J.

Biol Blood Marrow Transplant. 2015 Jan;21(1):16-23. doi: 10.1016/j.bbmt.2014.10.029. Epub 2014 Nov 12. Review.

8.

High levels of B-cell activating factor in patients with active chronic graft-versus-host disease.

Sarantopoulos S, Stevenson KE, Kim HT, Bhuiya NS, Cutler CS, Soiffer RJ, Antin JH, Ritz J.

Clin Cancer Res. 2007 Oct 15;13(20):6107-14.

9.

Altered immune reconstitution of B and T cells precedes the onset of clinical symptoms of chronic graft-versus-host disease and is influenced by the type of onset.

Bohmann EM, Fehn U, Holler B, Weber D, Holler E, Herr W, Hoffmann P, Edinger M, Wolff D.

Ann Hematol. 2017 Feb;96(2):299-310. doi: 10.1007/s00277-016-2881-x. Epub 2016 Dec 9.

PMID:
27942862
10.

Aberrant B-cell homeostasis in chronic GVHD.

Sarantopoulos S, Ritz J.

Blood. 2015 Mar 12;125(11):1703-7. doi: 10.1182/blood-2014-12-567834. Epub 2015 Feb 2. Review.

11.

High levels of B cell activating factor during the peritransplantation period are associated with a reduced incidence of acute graft-versus-host disease following myeloablative allogeneic stem cell transplantation.

Cho BS, Min CK, Kim HJ, Lee S, Kim YJ, Lim JY, Jeong DC, Cho B, Kim HK, Eom KS, Cho SG, Kim DW, Lee JW, Min WS, Kim CC, Chung NG.

Biol Blood Marrow Transplant. 2010 May;16(5):629-38. doi: 10.1016/j.bbmt.2009.11.023. Epub 2009 Dec 4.

12.

Impact of acute and chronic graft-versus-host disease on human B-cell generation and replication.

Glauzy S, Soret J, Fournier I, Douay C, Moins-Teisserenc H, Peffault de Latour R, Maki G, Robin M, Socié G, Toubert A, Clave E.

Blood. 2014 Oct 9;124(15):2459-62. doi: 10.1182/blood-2014-05-573303. Epub 2014 Sep 2.

13.

Genetic variation in recipient B-cell activating factor modulates phenotype of GVHD.

Clark WB, Brown-Gentry KD, Crawford DC, Fan KH, Snavely J, Chen H, Savani BN, Kassim A, Greer JP, Schuening FG, Engelhardt BG, Jagasia MH.

Blood. 2011 Jul 28;118(4):1140-4. doi: 10.1182/blood-2010-09-310011. Epub 2011 May 31.

14.

CD19+CD21low B cells and CD4+CD45RA+CD31+ T cells correlate with first diagnosis of chronic graft-versus-host disease.

Greinix HT, Kuzmina Z, Weigl R, Körmoczi U, Rottal A, Wolff D, Kralj M, Kalhs P, Mitterbauer M, Rabitsch W, Edinger M, Holler E, Pickl WF.

Biol Blood Marrow Transplant. 2015 Feb;21(2):250-8. doi: 10.1016/j.bbmt.2014.11.010. Epub 2014 Nov 20.

15.

Significant differences in B-cell subpopulations characterize patients with chronic graft-versus-host disease-associated dysgammaglobulinemia.

Kuzmina Z, Greinix HT, Weigl R, Körmöczi U, Rottal A, Frantal S, Eder S, Pickl WF.

Blood. 2011 Feb 17;117(7):2265-74. doi: 10.1182/blood-2010-07-295766. Epub 2010 Nov 9.

16.

Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria.

Kuzmina Z, Gounden V, Curtis L, Avila D, Rnp TT, Baruffaldi J, Cowen EW, Naik HB, Hasni SA, Mays JW, Mitchell S, Baird K, Steinberg SM, Pavletic SZ.

Am J Hematol. 2015 Feb;90(2):114-9. doi: 10.1002/ajh.23885. Epub 2014 Nov 24.

17.

Alteration of naïve and memory B-cell subset in chronic graft-versus-host disease patients after treatment with mesenchymal stromal cells.

Peng Y, Chen X, Liu Q, Xu D, Zheng H, Liu L, Liu Q, Liu M, Fan Z, Sun J, Li X, Zou R, Xiang AP.

Stem Cells Transl Med. 2014 Sep;3(9):1023-31. doi: 10.5966/sctm.2014-0001. Epub 2014 Jul 10.

18.

Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.

Moon JH, Sohn SK, Lambie A, Ellis L, Hamad N, Uhm J, Gupta V, Lipton JH, Messner HA, Kuruvilla J, Kim D.

Biol Blood Marrow Transplant. 2014 Apr;20(4):556-63. doi: 10.1016/j.bbmt.2014.01.010. Epub 2014 Jan 18.

19.

Elevated numbers of immature/transitional CD21- B lymphocytes and deficiency of memory CD27+ B cells identify patients with active chronic graft-versus-host disease.

Greinix HT, Pohlreich D, Kouba M, Körmöczi U, Lohmann I, Feldmann K, Zielinski C, Pickl WF.

Biol Blood Marrow Transplant. 2008 Feb;14(2):208-19. doi: 10.1016/j.bbmt.2007.10.009.

20.

Immune cell subset counts associated with graft-versus-host disease.

Podgorny PJ, Liu Y, Dharmani-Khan P, Pratt LM, Jamani K, Luider J, Auer-Grzesiak I, Mansoor A, Williamson TS, Ugarte-Torres A, Hoegh-Petersen M, Stewart DA, Daly A, Khan FM, Russell JA, Storek J.

Biol Blood Marrow Transplant. 2014 Apr;20(4):450-62. doi: 10.1016/j.bbmt.2014.01.002. Epub 2014 Jan 6.

Supplemental Content

Support Center